journal article·2022-04

Dual stimuli-responsive dendronized prodrug derived from poly(oligo-(ethylene glycol) methacrylate)-based copolymers for enhanced anti-cancer therapeutic effect

Qiang Luo, Ling Lin, Qiaorong Huang, Zhenyu Duan, Lei Gu, Hu Zhang, Zhongwei Gu, Qiyong Gong, Kui Luo

Acta Biomaterialia· Volume 143
Publisher page

Abstract

In this study, we developed an enzyme- and pH-responsive dendronized poly(oligo-(ethylene glycol) methacrylate) (pOEGMA)-doxorubicin (DOX) polymeric prodrug, which combined the pOEGMA structure with a degradable peptide dendron. The introduction of the dendron in the prodrug hindered the entanglement of brush oligo-(ethylene glycol) (OEG) chains, allowed the prodrug to possess dual stimuli-responsiveness, and mediated self-assembly of the polymeric prodrug to form stable nanoparticles (NPs). Brush conformation of polyethylene glycol (PEG) side chains endowed the NPs with long-term circulation with a half-life of 16.0 h. The dual-responsive dendritic structure enhanced cellular uptake of NPs and facilitated drug release in response to overexpressed cathepsin B and an acidic pH in the tumor microenvironment, resulting in an enhanced therapeutic effect with a tumor inhibition rate of 72.9% for 4T1 tumor-bearing mice. The NPs were demonstrated to possess great hemocompatibility and biosafety. Therefore, this strategy could provide great insight for the design of poly(oligo-(ethylene glycol) methacrylate)-based copolymers as drug delivery carriers. STATEMENT OF SIGNIFICANCE: We propose a dual-stimuli-responsive dendronized strategy for improving the cancer therapeutic effect of the poly(oligo-(ethylene glycol) methacrylate) (pOEGMA)-based drug conjugates. The introduction of the functional dendron promotes self-assembly of the polymeric prodrug into nanoparticles, hindering the entanglement of brush oligo-(ethylene glycol) (OEG) chains in the conjugated drugs. The obtained poly OEGMA-GFLG-Dendron-NH-N=DOX nanoparticles maintains long circulation, while addresses the drug release issue due to the presence of high-density PEG. The drug delivery system exhibits a high therapeutic potentcy with negligible side effects.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Dendrimers and Hyperbranched Polymers · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (46)

Show source-provided references
1. Tumor delivery of macromolecular drugs based on the EPR effect10.1016/j.addr.2010.03.011 ↗
2. Principles of nanoparticle design for overcoming biological barriers to drug delivery10.1038/nbt.3330 ↗
3. Designing smart polymer conjugates for controlled release of payloads10.1021/acs.chemrev.8b00006 ↗
4. Engineered nanoparticles for drug delivery in cancer therapy10.1002/anie.201403036 ↗
5. Polymer conjugates as anticancer nanomedicines10.1038/nrc1958 ↗
6. Impact of surface polyethylene glycol (PEG) density on biodegradable nanoparticle transport in mucus ex vivo and distribution in vivo10.1021/acsnano.5b03876 ↗
7. PEGylation for enhancing nanoparticle diffusion in mucus10.1016/j.addr.2017.08.010 ↗
8. Amphiphilic peptide dendritic copolymer-doxorubicin nanoscale conjugate self-assembled to enzyme-responsive anti-cancer agent10.1016/j.biomaterials.2014.07.059 ↗
9. Stimuli-sensitive linear–dendritic block copolymer–drug prodrug as a nanoplatform for tumor combination therapy10.1002/adma.202108049 ↗
10. Polymeric conjugates for drug delivery10.1021/cm2031569 ↗
11. What is the future of PEGylated therapies?10.1517/14728214.2015.1113254 ↗
12. PEGylated PRINT nanoparticles: the impact of PEG density on protein binding, macrophage association, biodistribution, and pharmacokinetics10.1021/nl302638g ↗
13. Physico-chemical parameters that govern nanoparticles fate also dictate rules for their molecular evolution10.1016/j.addr.2011.09.009 ↗
14. Supramolecular nanoscale assemblies for cancer diagnosis and therapy10.1016/j.jconrel.2015.06.034 ↗
15. Evading immune cell uptake and clearance requires PEG grafting at densities substantially exceeding the minimum for brush conformation10.1021/mp400703d ↗
16. Core-clickable PEG- branch -azide bivalent-bottle-brush polymers by ROMP: grafting-through and clicking-to10.1021/ja108441d ↗
17. Well-defined degradable brush polymer–drug conjugates for sustained delivery of paclitaxel10.1021/mp3004868 ↗
18. A degradable brush polymer–drug conjugate for pH-responsive release of doxorubicin10.1039/C4PY01194E ↗
19. Well-defined diblock brush polymer–drug conjugates for sustained delivery of paclitaxel10.1039/C4BM00458B ↗
20. Theranostic unimolecular micelles based on brush-shaped amphiphilic block copolymers for tumor-targeted drug delivery and positron emission tomography imaging10.1021/am5002585 ↗
21. Modulating the cellular immune response of oligonucleotides by brush polymer-assisted compaction10.1002/smll.201701432 ↗
22. Effect of polymer side chains on drug delivery properties for cancer therapy10.1166/jbn.2017.2466 ↗
23. Synthesis and direct imaging of ultrahigh molecular weight cyclic brush polymers10.1002/anie.201101860 ↗
24. Arginine functionalized peptide dendrimers as potential gene delivery vehicles10.1016/j.biomaterials.2012.03.030 ↗
25. Dendronized heparin−doxorubicin conjugate based nanoparticle as pH-responsive drug delivery system for cancer therapy10.1016/j.biomaterials.2012.12.017 ↗
26. Dendronized supramolecular polymers10.1039/C4CC03119A ↗
27. Synthesis and thermo-/pH- dual responsive properties of poly(amidoamine) dendronized poly(2-hydroxyethyl) methacrylate10.1021/ma1000783 ↗
28. Synthesis of poly(OEOMA) using macromonomers via “Grafting-Through” ATRP10.1021/acs.macromol.5b01592 ↗
29. Stimuli-sensitive biodegradable and amphiphilic block copolymer-gemcitabine conjugates self-assemble into a nanoscale vehicle for cancer therapy10.1021/acsami.6b15232 ↗
30. Enzyme- and pH-sensitive branched polymer–doxorubicin conjugate-based nanoscale drug delivery system for cancer therapy10.1021/acsami.6b02006 ↗
31. Amphiphilic toothbrushlike copolymers based on poly(ethylene glycol) and poly(ε-caprolactone) as drug carriers with enhanced properties10.1021/bm100116g ↗
32. Bioapplications of RAFT polymerization10.1021/cr9001403 ↗
33. Drug delivery: brushing off antigenicity10.1038/s41551-016-0019 ↗
34. Stimuli-responsive nanocarriers for drug delivery10.1038/nmat3776 ↗
35. The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect10.1016/j.addr.2010.04.009 ↗
36. Branched polymer-based redox/enzyme-activable photodynamic nanoagent to trigger STING-dependent immune response for enhanced therapeutic effect
37. Synergistic therapy of a naturally-inspired glycopolymer-based biomimetic nanomedicine harnessing tumor genomic instability10.1002/adma.202104594 ↗
38. Influence of doxorubicin on apoptosis and oxidative stress in breast cancer cell lines10.3892/ijo.2016.3558 ↗
39. Effect of the polymer architecture on the structural and biophysical properties of PEG–PLA nanoparticles10.1021/acsami.5b01423 ↗
40. Targeted drug delivery to tumors: Myths, reality and possibility10.1016/j.jconrel.2011.06.001 ↗
41. Programmed size-changeable nanotheranostic agents for enhanced imaging-guided chemo/photodynamic combination therapy and fast elimination10.1002/adma.202100398 ↗
42. Cascade drug-release strategy for enhanced anticancer therapy10.1016/j.matt.2020.10.002 ↗
43. Polyprodrug nanomedicines: an emerging paradigm for cancer therapy
44. Enhanced antitumor efficacy by a cascade of reactive oxygen species generation and drug release10.1002/anie.201908997 ↗
45. Tumor-specific drug release and reactive oxygen species generation for cancer chemo/chemodynamic combination therapy
46. GSH-sensitive polymeric prodrug: synthesis and loading with photosensitizers as nanoscale chemo-photodynamic anti-cancer nanomedicine10.1016/j.apsb.2021.05.003 ↗